7. Hematologic Disorders Flashcards

1
Q

Hemostasis

Primary hemostasis
Platelet ____

Secondary hemostasis
____ cascade
____ formation

A

aggregation/plug
coagulation
fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Platelets

____ cell fragments from ____
150-400 million/mL of blood
Average life around ____ days

A

anuclear
megakaryocytes
7-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Platelet aggregation and formation of platelet plug
____
____
____

A

adhesion
activation
aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary Hemostasis

Endothelial damage
____ exposure- vWF, TF, laminin, fibronectin

Platelet Adhesion
____ binds Von Willebrand Factor
____ produced by endothelial cells, catches platelets

GP1b deficiency- ____

A

collagen
GP Ib-IX-V
vWF
bernard-soulier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Platelet activation

Caused by adhesion to ECM
Leads to degranulation and conformational change

Degranulation
____ granules- vWF, fibrinogen, FV, FXIII
____ granules- ADP, serotonin

Phospholipid membrane metabolism
Arachidonic acid release eventually leads to ____-> platelet activation and ____

____ and ____- platelet recruitment and activation

A

alpha
dense

thromboxane A2
aggregation

ADP
thromboxane A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Formation of Thromboxane

This is basically the breakdown of phospholipids.
• •

You have ____ which makes arachidonic acid.

Then you have these cox 1 and cox 2 that break down arachidonic acid into ____ and all these diff prostaglandins can cause through thromboxane synthase release of thromboxane A2 which activates the ____.

Also ____ which is important in inflammation.

____ which is kind of a protective prostaglandin within your gut if you remember that.

So this is the breakdown of phospholipid membranes and its important because some meds impact this and impact platelet activation and aggregation which is the whole point of why you’re taking these medications

A

phospholipase A2
prostaglandins
platelets

prostacyclines

PGE2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Platelet Activation

So again this is kind of a picture format of this.
• The platelet adheres to the ____. It becomes activated, the release of these
granules, the alpha and dense granules, that release ____ and serotonin which act on itself creating a ____ feedback mechanism that further activates platelets in the area and causes platelet aggregation.
• If you’ll note, the ADP interacts with the ____ receptor which we’ll talk about down the road as well.

A

endothelium
ADP
positive
P2Y12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary Hemostasis

Platelet Aggregation
____ integrin on platelets is the receptor for fibrinogen
Platelet Plug
TF activation

GPIIb/IIIa deficiency- ____

A

GPIIb/IIIa

glanzman thrombasthenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

We have endothelial cell damage, these platelets are flying by, the ____ factor basically catches these platelets causing conformational change and causing platelet activations, a release of ____ and ____ through these different granules that then feed back and cause further activation and aggregation of platelets becoming a ____. Hopefully that’s a simplified way of the whole platelet plug process.

A

vWF
ADP
TXA2
platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Secondary hemostasis

  • Fibrin clot
    Secondary hemostasis once you have this ____.

This should look somewhat familiar to you, you know your intrinsic and extrinsic pathway of the coagulation cascade, all these different factors.

Basically 1 through 13. All cause in the end, the formation of ____ which then causes fibrinogen to turn into ____. fibrin is basically these strands that hold the platelet plug together and mature and help you stop bleeding.

we’ll talk about different medications and deficiencies of some of these factors that can cause bleeding.
if you know basic physiology, you can figure most of this stuff out like how medications work, why people take medications, when to stop the medications and what happens when you stop.

A

platelet plug

thrombin
fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fibrin clot

Fibrinogen cleaved to ____
Fibrin is ____ and crosslinks platelets
Forms a hemostatic ____ and blood clot

A

fibrin
insoluble
platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lab tests

PT/INR
Tests ____ pathway
Factor ____

PTT
Tests ____ pathway
Factor ____

Bleeding time
Measures ____ function

A

extrinsic
I, II, V, VII, X

intrinsic
I, II, V, VIII, IX, X, XI, XII

platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Von Willebrand’s Disease

The most ____ hereditary coagulation abnormality
1/100 of general population

Deficiency of von Willebrand factor
vWF binds to other proteins (____/collagen)
vWF binds ____

Symptoms
____, easy bruising, nosebleeds, ____ bleeding, heavy menstrual periods

A

common

factor VIII
platelets

bleeding
gingival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Von Willebrand Disease

Type 1- ____ defect (85%) Failure to secrete, or cleared more quickly
Many ____ or mild symptoms
Type 2- ____ defect (15%) Type 3- ____ of production (rare)

A

quantitative
asymptomatic
qualitative
absence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Von Willebrand Disease

Diagnosis- Labs
____
measures amount of vWF (____)

____ activity- vWF activity Measures how well vWF works (____)

vWF multimer study
Evaluates ____

Factor VIII levels ____

____ PTT

A

vWF:Ag
quantitative

ristocetin cofactor
qualitative

structure

decreased

elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Von Willebrand Disease

Treatment-
____ (IV or IN)- minor trauma
Stimulates vWF release from ____ bodies in endothelial cells

____- major trauma

____ vWF

Cryoprecipitate
____, vWF, ____, XIII, ____

Transfusions

A

dDAVP
weibel palade

factor VIII

recombinant

fibrinogen
VIII
fibronectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hemophilia

Hemophilia A
____ deficiency (____)
~____% of hemophilia cases
30% caused by new mutations

Hemophilia B
Factor ____ deficiency (____) ~20% of hemophilia cases

Hemophilia C
Factor ____ deficiency (____)

A

factor VIII
x-linked recessive
80

IX
X-linked recessive

XI
autosomal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hemophilia

Signs/Symptoms 
Variable
Internal \_\_\_\_
Hemarthrosis, Muscle/soft tissue, Retroperitoneal
Petechiae characteristically \_\_\_\_

Complications
____ damage
Transfusion reactions
____ hemorrhage

A

bleeding
absent

joint
intracranial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hemophilia labs

Bleeding Time
____

Prothrombin/INR
____

PTT
____

Factor ____ and ____ assays to confirm diagnosis

A

normal
normal
prolonged

VIII
IX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Again hemophilia’s basically with factor ____ and factor ____ which is within your clotting cascade.

A

8

9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hemophilia

Treatment
Recombinant factor ____ Recombinant factor ____
Plasma derived ____ or FIX ____ Acid / Aminocaproic Acid
____
____

A
VIII
IX
FVIII
tranexamic
DDAVP
cryoprecipitate
22
Q

Aminocaproic Acid/Tranexamic Acid

Amicar and TXA
Amicar- Derivative of \_\_\_\_
TXA- synthetic analog of \_\_\_\_
Lysine inhibits \_\_\_\_, such as proteolytic enzymes like \_\_\_\_
Swish for \_\_\_\_ minutes, spit or swallow
A
lysine
lysine
enzymes
plasmin
1-2
23
Q

Liver

Regulates ____
Makes ____ and proteins
Removes ____ and drugs Makes bile for ____ digestion

A

blood glucose
amino acids
toxins
fat

24
Q

Causes of Liver Failure

Viral
____

Metabolic
____
____

Hereditary
____
NAFLD- non alcoholic fatty liver disease

A

hepatitis A-E
EtOH
drugs
autoimmune

25
Q

Coagulation Cascade

So liver failure - all of these factors are made in your liver except for factor ____.

So someone with fulminant liver disease, someone on the transplant list, it can be very dangerous to take a bunch of teeth out.
• People have died from having their teeth out. There’s a case in Portland Oregon
where OS took out a bunch of teeth and this person bled to death.

A

8

26
Q

Acquired

Medication induced 
\_\_\_\_
\_\_\_\_
\_\_\_\_ inhibitor 
\_\_\_\_ inhibitor 
Anti-\_\_\_\_
A
warfarin
heparin
direct thrombin
factor Xa
platelets
27
Q

Warfarin

Decreases thrombosis
Mechanism of Action
Inhibits \_\_\_\_ 
Antagonizes the recycling of \_\_\_\_
II,VII,IX,X,protein C and S 
Half-life about \_\_\_\_ hours
A

vitamin K epoxide reductase
vitamin K1
35

28
Q

Warfarin

Indications- Prevent thrombosis
____ (PE)/Deep Vein Thrombosis (DVT) treatment and prophylaxis
____
____ heart valves
____ states (Factor V Leiden, APLS, etc.)

A

pulmonary embolus
atrial fibrillation
artificial
hypercoagulable

29
Q

Virchow’s Triad

  • ____ Injury
  • ____
  • Stasis of ____
    Hopefully this is something that you’ve seen before.

Why people get thrombosis or blood clots, typically you have these 3 things in conjuction.
Endothelial injury or trauma of some sort, stasis of blood flow, and a hypercoagulable state.
Injury is self-explanatory, stasis of blood flow people after surgery like big GI surgeries are laying in bed for a long time as they recover. They’re more prone to getting DVTs. People sitting on a long plane ride, people have heard of getting DVTs (lol do we have DVTs
from chronic studying ̄_(ツ)_/ ̄ ) he recommends we get up & walk)
Hypercoagulability - people with cancer or pregnant, there’s a lot of different reasons to
be hypercoagulable. Genetic problems like factor 5 leiden.

A

endothelial
hypercoagulability
blood flow

30
Q

Factor V Leiden

this is one of the most common heriditary hypercoagulable disorders, particularly with people of european descent.
• •
A mutated factor 5 does not get deactivated by the activated protein C. So activated protein C typically deactivates ____.
when you deactivate factor 5 obviously you’re not forming ____ and then you don’t form ____. If you’re not deactivating it because its mutated then you continue to form thrombin and you’re ____ because you’re forming too many clots basically.

A

factor 5
thrombin
blood clots
hypercoaguable

31
Q

Warfarin

Monitored by ____
Normal INR is ____

Risk of ____ when 1st started
– ____ inactivate clotting factors

A

PT/INR
1

thrombosis

protein C/S

32
Q

What to do if your patient is taking warfarin?

CHEST Guidelines
In patients who require temporary interruption of a VKA before surgery, we recommend stopping VKAs approximately ____ days before surgery instead of stopping ____ a shorter time before surgery (Grade 1C).

recommend resuming VKAs approximately ____h after surgery (evening of or next morning) and when there is adequate hemostasis instead of later resumption of ____

In patients who require a ____ dental procedure, we suggest continuing VKAs with coadministration of an oral prohemostatic agent or stopping VKAs 2 to 3 days before the procedure instead of ____ strategies

Check INR ____hrs prior to procedure!!!

A

VKAs
5
12 to 24

12 to 24
VKAs

minor
alternative

24-48

33
Q

Warfarin

Reversal Agents
____ (IV or Oral)
Fresh Frozen Plasma (FFP) Contains all ____
Has an INR of ____

4-factor prothrombin complex concentrate
Beriplex, Octaplex, Kcentra, Cofact
Factor ____,VII, ____, X, ____ and S

A

vitamin K
factors
1.6

II
IX
protein C

34
Q

Heparin

Naturally occurring anticoagulant in ____ and mast cells.

Prevents ____ formation and propagation

Mechanism of Action
Binds and activates ____
Activated ATIII inactivates ____ and some factors, especially factor Xa

A

basophils
clot

antithrombin III
thrombin

35
Q

Secondary Hemostasis

Heparin

Indications
____ treatment and prophylaxis
____ Fibrillation
____ (acute coronary syndrome)/NSTEMI (non ST- elevation myocardial infarction)
____ bypass / ECMO (extracorporeal membrane oxygenation)
____/dialysis

A
DVT
atrial
ACS
cardiopulmonary
hemofiltration
36
Q

Heparin

Unfractionated heparin (UFH) vs. Low molecular weight heparin (LMWH)

UFH - half life ____ minutes, monitored by PTT
Given ____ or SC

LMWH (dalteparin, enoxaparin)
Half life ~____ hours, not monitored by ____
Given ____ or SC

A

90
IV

4
PTT
IV

37
Q

Heparin - CHEST Guidelines

Perioperative therapeutic IV UFH
Suggest stopping UFH ____ h before surgery instead of closer to surgery.

Perioperative therapeutic SC LMWH
Suggest administering the last preoperative dose of LMWH approximately ____ h before surgery instead of 12 h before surgery.
high-bleeding-risk surgery, we suggest resuming therapeutic-dose LMWH ____ h after surgery instead of resuming LMWH within 24 h after surgery

A

4-6
24
48-72

38
Q

Heparin

Reversal with ____
Binds to heparin and LMWH

Adverse effects of heparin
____
____

A

protamine sulfate

heparin induced thrombocytopenia, thrombosis
hyperkalemia

39
Q

Direct Thrombin Inhibitor

Dabigatran (Pradaxa)
Half-life ____ hours
Reversible with ____ (Praxbind)

Argatroban
For ____

Bivalirudin/Lepirudin/Desirudin (Iprivask)

Pradaxa has reversal agent (Praxbind)- idarucizumab

A

12-14
idarucizumab
heparin induced thrombocytopenia (HIT)

40
Q

Factor Xa Inhibitor

____ (Xarelto)
____ (Eliquis)
____ (Savaysa)

No specific ____ agents

A

rivaroxaban
apixaban
edoxaban
reversal

41
Q

Discontinuation of medications

Should be decided by ____ physician

Dabigatran (Pradaxa), Rivaroxaban (Xarelto), Apixaban (Eliquis), Edoxaban (Savaysa)
Typically stop ____ days prior
Restart after hemostasis ____ days after procedure, or ____ days if high bleeding risk procedure

A

prescribing

2-3
1-2

2-3

42
Q

Antiplatelets

\_\_\_\_
Clopidogrel (Plavix) 
\_\_\_\_ (Ticlid) 
\_\_\_\_ (Effient) 
Ticagrelor (Brilinta) 
\_\_\_\_ (Kengreal)
A

aspirin
ticlopidine
prasugrel
cangrelor

43
Q

Indications for antiplatelets

Acute ____ syndrome Prevention of ____ thrombosis
____ prevention

A

coronary
stent
stroke

44
Q

Antiplatelets

Aspirin
Aspirin basically inhibits ____.
End result of the degradation of phospholipids is ____.

A

cox 1 or cox2

thromboxane A2

45
Q

Platelet Activation

Phospholipid membrane metabolism
Arachidonic acid release eventually leads to ____-> platelet activation and aggregation
____- platelet recruitment and activation

A

thromboxane A2

ADP and thromboxane A2

46
Q

Formation of Thromboxane

Aspirin blocks all of that and blocks the whole cascade

NSAIDS all work on these similar proteins that help with pain and inflammation and prolong ____ because of the decreased thromboxane A2 then decrease platelet ____ and aggregation

A

bleeding

activation

47
Q

Antiplatelets

Irreversibly binds P2Y12
____ (Plavix)
____ (Effient)

Reversibly binds P2Y12
____ (Brilinta)
____ (Kengreal)

A

clopidogrel
prasugrel

ticagrelor
cangrelor

48
Q

Plavix decreases platelet activation

If you’re blocking this receptor you’re blocking platelet ____ and platelet aggregation disrupting ____. Hopefully you now understand why people take these and how they work.

A

activation

blood clots

49
Q

Perioperative management of antiplatelets

American College of Chest Physicians

In patients who are receiving ASA for the secondary prevention of cardiovascular disease and are having minor ____ or dermatologic procedures or cataract surgery, we suggest ____ ASA around the time of the procedure instead of stopping ASA 7 to 10 days before the procedure

In patients at modrate to high risk for cardiovascular events who are receiving ASA therapy and require noncardiac surgery, we suggest ____ ASA around the time of surgery instead of stopping ASA 7 to 10 days before surgery (Grade 2C).In patients at low risk for cardiovascular events who are receiving ASA therapy, we suggest stopping ASA ____ days before surgery instead of continuation of ASA

A

dental
continuining

contiuning
7-10

50
Q

Discontinuation of medications

Should be decided by prescribing ____!

A

physician